Breaking News Instant updates and real-time market news.

FICO

Fair Isaac

$336.80

2.56 (0.77%)

18:40
11/13/19
11/13
18:40
11/13/19
18:40

Fair Isaac director sells 6K shares of common stock

In a regulatory filing, Fair Isaac disclosed that its EVP James Wehmann sold 6K shares of common stock on November 12th. The total transaction size was $2M.

FICO Fair Isaac
$336.80

2.56 (0.77%)

08/01/19
WELS
08/01/19
NO CHANGE
Target $415
WELS
Outperform
Fair Isaac price target raised to $415 from $310 at Wells Fargo
Wells Fargo analyst William Warmington raised his price target for Fair Isaac to $415 from $310 following better than expected quarterly results. The analyst reiterates an Outperform rating on the shares.
08/14/19
COWN
08/14/19
NO CHANGE
COWN
FHFA rule a risk to FICO, but competition not a guarantee, says Cowen
Cowen Washington Group Research analyst Jaret Seiberg believes the rule announced yesterday by the Federal Housing Finance Agency establishing a process for Fannie Mae (FMNA) and Freddie Mac (FMCC) to adopt new credit scoring models is a positive for Vantage Score and a risk to Fair Isaac's (FICO) FICO. However, the FHFA process "is measured in years and not weeks," so this will not be a quick effort even if Vantage Score can win approval of its model, Seiberg tells investors in a research note. Further, there is no guarantee that FICO will have a rival to its credit score model for mortgages backed by Fannie and Freddie as the process is long and complicated to get new models approved, adds the analyst. With that said, Seiberg points out that FICO is not guaranteed to have one of its credit scoring models approved at the end of this process. After dropping yesterday, shares of Fair Isaac are down another 2.5% to $328.80 in early trading.
10/14/19
BARD
10/14/19
INITIATION
Target $352
BARD
Outperform
Fair Isaac initiated with an Outperform at Baird
Baird analyst Jeffrey Meuler initiated coverage of Fair Isaac with an Outperform rating and $352 price target.
10/15/19
BARD
10/15/19
INITIATION
Target $352
BARD
Outperform
Baird initiates Fair Issac, better buyer after earnings
Baird analyst Jeffrey Meuler initiated coverage of Fair Isaac with an Outperform rating and $352 price target. The analyst noted the company has two "under-earnings" businesses with its Scores and Software divisions. Meuler believes both management and capital allocation has been highly additive but said he would be better buyers after the company reports Q4 and issues fiscal 2020 guidance.

TODAY'S FREE FLY STORIES

SLG

SL Green Realty

$86.93

1.18 (1.38%)

, AMZN

Amazon.com

$1,750.79

10.2 (0.59%)

07:31
12/09/19
12/09
07:31
12/09/19
07:31
Hot Stocks
SL Green Realty signs Amazon to 335,000 sq. ft. lease at 410 Tenth Ave., NY »

SL Green Realty (SLG)…

SLG

SL Green Realty

$86.93

1.18 (1.38%)

AMZN

Amazon.com

$1,750.79

10.2 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

RH

RH

$241.95

8.72 (3.74%)

07:31
12/09/19
12/09
07:31
12/09/19
07:31
Recommendations
RH analyst commentary  »

RH price target raised to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCKT

Rocket Pharmaceuticals

$22.37

2.61 (13.21%)

07:31
12/09/19
12/09
07:31
12/09/19
07:31
Recommendations
Rocket Pharmaceuticals analyst commentary  »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEP

American Electric

$92.36

-0.11 (-0.12%)

07:30
12/09/19
12/09
07:30
12/09/19
07:30
Conference/Events
American Electric management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

LHCG

LHC Group

$135.27

2.49 (1.88%)

07:30
12/09/19
12/09
07:30
12/09/19
07:30
Hot Stocks
LHC Group, LifePoint Health announce further expansion of JV »

LHC Group and LifePoint…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FATE

Fate Therapeutics

$13.64

0.07 (0.52%)

07:30
12/09/19
12/09
07:30
12/09/19
07:30
Recommendations
Fate Therapeutics analyst commentary  »

Fate Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIVN

Five9

$66.09

-0.62 (-0.93%)

07:30
12/09/19
12/09
07:30
12/09/19
07:30
Recommendations
Five9 analyst commentary  »

Five9 price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

07:30
12/09/19
12/09
07:30
12/09/19
07:30
General news
FX Update: The pound rallied to new highs »

FX Update: The pound…

OBSV

ObsEva

$4.60

0.29 (6.73%)

07:25
12/09/19
12/09
07:25
12/09/19
07:25
Conference/Events
ObsEva to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

ADBE

Adobe

$306.24

3.24 (1.07%)

07:22
12/09/19
12/09
07:22
12/09/19
07:22
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 23

    Jan

AUTL

Autolus Therapeutics

$14.60

-0.18 (-1.22%)

07:19
12/09/19
12/09
07:19
12/09/19
07:19
Conference/Events
Autolus Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

SPCE

Virgin Galactic

$7.28

0.07 (0.97%)

07:17
12/09/19
12/09
07:17
12/09/19
07:17
Initiation
Virgin Galactic initiated  »

Morgan Stanley cites…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

TCBI

Texas Capital

$57.82

0.76 (1.33%)

, IBTX

Independent Bank

$59.23

1 (1.72%)

07:15
12/09/19
12/09
07:15
12/09/19
07:15
Hot Stocks
Independent Bank, Texas Capital Bancshares enter $5.5B all-stock merger »

Texas Capital Bancshares…

TCBI

Texas Capital

$57.82

0.76 (1.33%)

IBTX

Independent Bank

$59.23

1 (1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZLAB

Zai Lab

$41.25

0.11 (0.27%)

07:15
12/09/19
12/09
07:15
12/09/19
07:15
Recommendations
Zai Lab analyst commentary  »

Citi opens 'positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEGI

Pattern Energy

$27.45

0.02 (0.07%)

07:14
12/09/19
12/09
07:14
12/09/19
07:14
Hot Stocks
Pattern Energy announces expiration of 'Go-Shop Period' »

Pattern Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$171.49

7.13 (4.34%)

07:12
12/09/19
12/09
07:12
12/09/19
07:12
Downgrade
3M rating change  »

Citi downgrades 3M to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

FTV

Fortive

$72.86

0.5 (0.69%)

, MMM

3M

$171.49

7.13 (4.34%)

07:11
12/09/19
12/09
07:11
12/09/19
07:11
Upgrade
Fortive, 3M rating change  »

Citi upgrades Fortive to…

FTV

Fortive

$72.86

0.5 (0.69%)

MMM

3M

$171.49

7.13 (4.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

ORAN

Orange SA

$15.02

-0.055 (-0.36%)

07:10
12/09/19
12/09
07:10
12/09/19
07:10
Downgrade
Orange SA rating change  »

Orange SA downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMDA

Kamada

$7.36

-0.025 (-0.34%)

07:10
12/09/19
12/09
07:10
12/09/19
07:10
Hot Stocks
Kamada enters into binding term sheet, sees product adding $8M-$10M in revenue »

Kamada announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSIQ

Canadian Solar

$18.35

0.39 (2.17%)

07:09
12/09/19
12/09
07:09
12/09/19
07:09
Hot Stocks
Canadian Solar authorizes $150M share repurchase program »

Canadian Solar announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETNB

89bio

$28.38

0.86 (3.13%)

07:09
12/09/19
12/09
07:09
12/09/19
07:09
Initiation
89bio initiated  »

89bio initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SONG

Akazoo

$5.40

-0.12 (-2.17%)

07:08
12/09/19
12/09
07:08
12/09/19
07:08
Earnings
Akazoo reports Q3 EPS EUR0.03 vs, EUR0.02 last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECC

Eagle Point Credit

$15.03

-0.01 (-0.07%)

07:08
12/09/19
12/09
07:08
12/09/19
07:08
Upgrade
Eagle Point Credit rating change  »

Eagle Point Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$122.36

1.6 (1.32%)

07:07
12/09/19
12/09
07:07
12/09/19
07:07
Conference/Events
Texas Instruments management to meet with UBS »

Dinner Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 16

    Dec

KALV

KalVista

$14.36

0.25 (1.77%)

, MRK

Merck

$88.84

0.09 (0.10%)

07:06
12/09/19
12/09
07:06
12/09/19
07:06
Hot Stocks
KalVista says KVD001 does not meet primary endpoint »

KalVista Pharmaceuticals…

KALV

KalVista

$14.36

0.25 (1.77%)

MRK

Merck

$88.84

0.09 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.